Published in Pain and Central Nervous System Week, November 18th, 2002
Levels of an antibody called anti-MOG were found to be consistently elevated in the most severely affected patients. The authors of the report said that the antibody may be directly responsible for nerve damage in the disease, or it may be a byproduct of the actual destructive process. In either event, the finding should open up many new avenues of research and potential therapy.
In MS patients, scarring (sclerosis) replaces myelin, a substance that normally insulates the nerves and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.